Ruboxistaurin
id:
ruboxistaurin-284-11254169
title:
Ruboxistaurin
text:
Ruboxistaurin is an investigational drug for diabetic retinopathy being investigated by Eli Lilly and Company. It is a member of the bisindolylmaleimide family. In February 2006, Lilly submitted a New Drug Application for ruboxistaurin, and on August 18, 2006, Lilly received an approvable letter from the US FDA for ruboxistaurin, with a request for an additional clinical trial, which would take 5 years to complete. Lilly has not made any further request for approval and ruboxistaurin is not appr
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Ruboxistaurin
date created:
date modified:
2023-12-20T19:34:00Z
main entity:
{"identifier":"Q7376181","url":"https://www.wikidata.org/entity/Q7376181"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/79/Ruboxistaurin.svg","width":512,"height":628}
fields total:
13
integrity:
15